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Journeys in The Country of The Blind: Entanglement Theory and
The Effects of Blinding on Trials of Homeopathy and Homeopathic
Provings
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Department of Chemistry, Imperial College, London SW7 2AZ, UK
The idea of quantum entanglement is borrowed from physics and developed into an algebraic argument
to explain how double-blinding randomized controlled trials could lead to failure to provide unequivocal
evidence for the efficacy of homeopathy, and inability to distinguish proving and placebo groups in
homeopathic pathogenic trials. By analogy with the famous double-slit experiment of quantum physics,
and more modern notions of quantum information processing, these failings are understood as blinding
causing information loss resulting from a kind of quantum superposition between the remedy and
placebo.
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Introduction
History records that at the Battle of Copenhagen in 1801 the
then Vice-Admiral Nelson famously chose to ignore a direct
order from his Commander-in-Chief to withdraw. Putting a
telescope to his blind eye, Nelson said, ‘I have only one eye—I
have a right to be blind sometimes. I really do not see the
signal’ (1).
A cavalier piece of battle-winning bravado perhaps, but
similar ‘signal eradicating’ blindness (imposed this time in the
name of scientific rigour) (2) could be affecting randomized
placebo-controlled trials of (i) homeopathy and (ii) homeo-
pathic pathogenic trials (HPTs) (provings). In case (i), double-
blinding could ensure double-blind randomized controlled
trials (DBRCTs) are intrinsically incapable of providing
unequivocal evidence for or against this controversial ther-
apy’s efficacy beyond placebo; while in the second case (ii),
double-blinding could prevent verum and placebo proving
groups being distinguished from each other. In this article, we
shall examine how these effects of blinding can be rationalized
and unified in terms of the latest quantum theoretical notions
of macroentanglement (3) and information loss (4).
RCTs and Ideology: ‘If Gold Rust,
What Shall Iron Do?’
Developed as a ‘gold standard’ for testing efficacy of drugs
and therapeutic procedures (5), the reputation of the DBRCT
has become somewhat tarnished of late. Reporting in The
Lancet, a recent Swiss meta-analysis (6) claimed to show that
the efficacy of homeopathy was no better than placebo. This
led The Lancet’s editor and other commentators, including
some elements of the media, to ‘read homeopathy its last
rights’ (7). However, detailed examination of The Lancet
meta-analysis shows that out of the well over one hundred
trials and previous meta-analyses, the authors actually made
use of the only eight that happened to show homeopathy was
no better than placebo. Not surprisingly, such faulty metho-
dology, biased conclusions and poor presentation were roundly
criticized by many serious researchers in the field (8–12).
However, these short-comings have so far failed to make any
impression on an essentially biased conventional scientific
community, and an equally jaundiced media apparently less
intent on objective reporting than writing off homeopathy as
dead and buried. It is interesting to speculate why.
The increasing hegemony of evidence-based, biomolecular
medicine (13) ensures the continuation of attacks on homeo-
pathy and many CAMs for being at best a placebo response,
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prescribed by homeopaths are so dilute, no molecules of the
original substance can remain. Therefore, homeopathy’s
detractors argue, homeopathy cannot possibly work because
how can nothing do something, i.e. bring about cure? This has
led to homeopathy arguably being more severely tested via
DBRCTs than any other therapeutic modality (including
conventional biomedicine). Although on balance, the number
of trials performed seems to favor homeopathy (14–17),
skeptics remain unconvinced and repeatedly call for yet more
‘definitive’ trials that ‘prove’ homeopathy is no better than
placebo (5).
The ideological basis of DBRCTs implicitly assumes that
specific effects (e.g. of the remedial substance) and non-
specific (contextual) effects of the therapeutic process (e.g.
consultation) can be separated and treated independently of
each other (18). Though the DBRCT ethos is fully consistent
with a centuries-old reductionist agenda (and its ontological
division of observers from the objects of their observation),
it is a worldview that has been effectively challenged by
the discoveries of modern quantum theory, i.e. non-locality
and entanglement.
An Entanglement Metaphor for Homeopathy?
Entangled entities behave as one inseparable holistic unit,
whose totality cannot be deduced from any of its parts. Non-
locality has been defined as ‘the mysterious ability of nature
to enforce correlations between separated but entangled parts
of a quantum system that are out of speed-of-light contact:
to reach instantaneously across vast spatial distances, or even
across time itself, to ensure that the parts of a quantum system
are made to match’ (19). This means that observation of
one part of an entangled system instantaneously provides
information about the rest, provided one knows how the
system is entangled. However, attempts to observe the parts of
an entangled system as separate entities, destroys the whole.
While non-locality and entanglement have been experimen-
tally demonstrated at the nanoscopic level of particles, atoms
and even molecules (20), macroentanglement between every-
day objects and people is still a matter of conjecture. Indeed,
the non-commuting algebraic formulation of orthodox quan-
tum theory (which contains the extremely small number called
Planck’s constant, h ¼ 6.626 * 10
 34 Js
 1) would appear to
preclude such quantum effects between macroscopic objects/
entities. Nevertheless, it is proving increasingly possible to
conceive non-locality and entanglement in a similar but less
restricting algebraic (21,22) or, indeed non-algebraic context
(23), and usefully apply these concepts to phenomenological
problems arising out of CAM research. Thus, Gernert (24)
defines a ‘common pre-arranged context’ which he suggests
characterizes the preparation to be made in advance (or
naturally given conditions) in order to enable entanglement.
His development of this idea also leads to ways of considering
macroentanglement as a possible explanation of significant
correlations found between subjects’ brain function in
carefully performed experiments on spatially separated pairs
of human subjects (25,26).
Weatherley-Jones et al. (18) had already suggested the
reason DBRCTs apparently fail to unequivocally demonstrate
the efficacy of homeopathy, is because specific and
non-specific effects of the therapeutic process are actually
interdependent and mutually correlated. Thus, according to a
holistic paradigm, the methodologies used in DBRCTs, and
the loss of information such techniques imply, must necessar-
ily destroy the very thing they are trying to investigate. This
theme was developed further into a critique of DBRCT
methodology (27) couched in terms of a developing algebraic
metaphor of the homeopathic therapeutic process called
PPR entanglement (22). The latter considers that macro-
entanglement between the patient, practitioner and remedy can
facilitate the therapeutic process.
Thus, patient (Px), practitioner (Pr), and remedy (Rx) states
are envisaged as expressible in terms of wave functions; cPx,
cPr, cRx, each expressing a multitude of states. However, only
two for each will be considered. If jni denotes a state with
wave function cn, then in any potentially therapeutic situation,
Px may be considered in a state of wellness (jPx"i)o r
unwellness (jPx#i); Pr may be helpful (jPr"i) or unhelpful
(jPr#i); and the remedy may be curative (jRx"i) or non-
curative (jRx#i). Using the three-way entanglement formalism
of Greenberger, Zeilinger and Horne (28), a maximally
entangled state wave function between Px, Pr and Rx may be
written as follows:
jCPPRi¼
1
ﬃﬃﬃ
2
p jPx"Pr"Rx"i þ Px#Pr#Rx#i ðÞ ð 1Þ
Also, in orthodox quantum theory, experimental observa-
tions are described by operators. There is a connection
between wave functions (jyi and its complex conjugate hyj),
operators (V, and the observations associated with them), and
the outcomes of measurements, leading to an ‘expectation
value’ (hWi). This is the mean value of an observable after a
series of experimental observations:
hyjVjyi¼hW ðÞ i ð 2Þ
A similar equation can be written to describe the outcome of
the therapeutic entangled interaction between Px, Pr and Rx
leading to an observed overall change in symptoms, DSx (29):
hCPPRjPrjCPPRi¼hDSx ðÞ i ð 3Þ
where jCPPRi represents the PPR entangled state wave
function, hCPPRj its complex conjugate and Pr denotes the
‘homeopathic operator’ (and the ‘therapeutic state space’
created by Pr).
It is worth noting that although Equations (2) and (3) look
superficially similar, in (2) the self-adjoint operator V is an
entity essentially independent of that which it operates upon
(i.e. the wave function jyi and its complex conjugate hyj).
However, in (3), the practitioner Pr is functioning both as the
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state wave function jCPPRi (and its complex conjugate,
hCPPRj) that Pr operates upon. In this sense, the Pr operates
to ‘reflect back’ the state of Px and the notion of cure. Thus the
homeopathic operator Pr is an ‘active mirror’. Pr embodies
the homeopathic operator Pr, which includes ‘generating’ the
‘state space’ in which therapy takes place. In this respect,
Equation (3) may be considered non-linear: Pr may be
thought of as helping to create both the conditions for cure
(the homeopathic operator, Pr) and being entangled with the
curative PPR state. Thus, Pr’s function is in helping to create a
healing ‘space’ (also denoted by Pr) for Px and then appearing
and operating within that space as part of the PPR entangled
state.
Entanglement-Breaking Effect of DBRCTs
on Homeopathy
Weatherley-Jones et al. (18) describe how two types of
DBRCT have been used to test the efficacy of homeopathy in
(i) specific, non-individualized homeopathic medicines (30–
32) and (ii) individualized homeopathic prescribing (33–36).
Generally, DBRCTs deemed of higher quality tend to show
less significant results than those of lesser quality. Weatherley-
Jones et al (18) then ask whether this is ‘...because homeop-
athy is nothing more than a placebo effect or does the
evaluation of a homeopathic approach create particular
challenges for a placebo-controlled trial?’ The entanglement
model developed earlier and outlined in Equations (1) and (3)
could help to throw some light upon this question.
DBRCTs of Specific Non-Individualized
Homeopathic Medicines
If a non-individualized homeopathic medicine is considered as
one prescribed with little or no intervention by a practitioner,
Pr, then in terms of Equations (1) and (3), this would mean
there would be no opportunity for entanglement with Pr. Thus,
in Equation (1), jPri becomes 0. Consequently, Equation (1)
reduces to:
jCPPRi¼
1
ﬃﬃﬃ
2
p jPx":0:Rx"i þ jPx#:0:Rx#i ðÞ ¼ 0 ð4Þ
In other words, the PPR entangled state wave function (and
therefore also that of its complex conjugate hCPPRj) collapse
to zero. But a further conclusion can be drawn. With no
practitioner Pr, then there can be no homeopathic operator/
state-space, Pr, i.e. Pr ¼ 0. Substituting into Equation (3)
gives:
hCPPRjPrjCPPRi¼h 0j0j0i¼hDSx ðÞ i ¼ 0 ð5Þ
That is, the expectation value h(Sx)i also becomes 0, which
means that no change in symptoms can be expected. Thus, the
more rigorously DBRCT methodology is applied to the testing
of non-individualized homeopathic medicines, the more an
entanglement model of the homeopathic process predicts how
they are unlikely to provide significant results in terms of an
observable and therapeutic change in symptoms.
DBRCTs of Individualized Homeopathic Prescribing
The entanglement argument here is more subtle. Clearly,
a practitioner Pr is now involved and may entangle with Px
and Rx, so that initially, Equation (1) holds, i.e.
jCPPRi¼
1
ﬃﬃﬃ
2
p jPx"Pr"Rx"i þ Px#Pr#Rx#i ðÞ
However, under the conditions of the DBRCT protocol,
crucially Pr does not know if the prescribed remedy is verum
or placebo.
It is worth pointing out that there are situations in real
homeopathic practice where a practitioner might intentionally
give a placebo (e.g. sac. lac.) as a second prescription, for
example, when Pr has assessed that a previous remedy’s action
is not exhausted, yet Px is still experiencing symptoms (37). It
should be emphasized that this is not the case in an DBRCT
designed to test individualized homeopathic prescribing,
as although it is the Pr’s intention is to give the prescribed
remedy, blinding ensures that it remains uncertain as to
whether that intention has been met.
How might this affect the therapeutic outcome? ‘The
homeopaths had been instructed to conduct their consultations
as usual and consider that all patients received real homeo-
pathic treatment, not to think about whether patients were on
placebo or real treatment, and to consider that lack of reaction
to remedies was due to factors documented in the homeopathic
literature. Thus, the reaction of patients to any specific effects
of the prescription could affect the homeopath, potentially
influencing the nature of the consultation. In this way, the
specific effect may impact on the non-specific effect’ (18).
Thus, in order to comply with implicit assumptions inherent
in the DBRCT methodology, homeopathic practitioners are
expected to engage in a highly questionable (and ultimately
confusing) form of self-deception that would be utterly
unthinkable in a real therapeutic situation (38,39).
Thus, in the light of Pr’s crucial uncertainty over whether Px
received verum or placebo Pr cannot ‘reflect’ the entangled
state wave function jCPPRi to give its complex conjugate,
hCPPRj, so that Pr ¼ 0, and hCPPRj¼0, leading algebraically
as follows:
hCPPRjPrjCPPRi¼h 0j0jCPPRi¼0 ¼hDSx ðÞ ið 6Þ
That is, same result as in Equation (5), and the expectation
value h(DSx)i tends to 0, meaning that no change in symptoms
can be expected. Thus, the more rigorously individualized
homeopathic prescribing is tested via DBRCTs, the more
an entanglement model of the homeopathic process predicts
they would fail to provide significant results in terms of an
observable and therapeutic change in symptoms.
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‘Collapse’ of the Therapeutic Effect
On the basis of these conclusions, it is interesting to consider
the DBRCT methodology as an observational process.
Equations (5) and (6) indicate that a possible effect of the
DBRCT methodology is to reduce the PPR entangled state
wave function (jCPPRi) and its complex conjugate (hCPPRj),
to zero.
In orthodox quantum theory, based on the positivist
Copenhagen Interpretation (CI) (40) such a process is deemed
to occur as a direct result of the observational process. It is
called ‘the collapse of the wave function’. While unobserved,
a particle is considered to exist in an indeterminate state whose
evolution in time is expressed by its wave function. However,
observation causes the wave function to ‘collapse’, and a
particle is observed, whose complementary position and
momentum are related via Heisenberg’s Uncertainty Principle.
Thus, in CI, the act of observation in part creates that which is
observed. The price of knowledge therefore is the loss of an
underlying (ontological) physical reality. It could be argued
that by its very nature, the DBRCT is an observational pro-
cedure which can ‘collapse’ jCPPRi and its complex conjugate
hCPPRj, and is having a similar ‘reality-losing’ effect here, i.e.
the loss or ‘collapse’ of the homeopathic effect. Thus the PPR
entanglement model is implying that the observational stance
taken during the DBRCT methodology to the investigation of
homeopathy’s efficacy essentially disrupts the very thing it is
trying to observe. This suggests that the application of the
DBRCT methodology to the study of homeopathy is funda-
mentally flawed, in agreement with Weatherley-Jones et al.’s
(18) conclusions based on clinical findings.
There is one further conclusion to be drawn from the above
treatment. The loss of information arising out of the effect of
blinding to what is remedy and what is placebo, could result in
quantum interference, i.e. entanglement, between them. It is
therefore the formation of a remedy–placebo entangled state
that leads to the breaking of entanglement between patient,
practitioner and remedy.
Thus, an algebraic treatment based on a patient–
practitioner–remedy macroentanglement theory demonstrates
that imposition of blinded DBRCT methodological conditions
could effectively proceed as follows:
  Impede PPR entanglement in trials of non-individualized
homeopathic remedies (where the remedy has been
selected purely on the basis that it has previously been
used to treat the conventional medically diagnosed
condition, and not on standard homeopathic practice of
individualized case taking).
  Break PPR entanglement once it has formed in trials
of individualized homeopathic prescribing (where the
remedy is selected according to standard homeopathic
practice of taking the individual case, but neither test
subject nor practitioner know if verum or placebo were
actually given during the trial).
The more rigorously, therefore, the blinded DBRCT
methodology is applied to testing the efficacy of homeopathy,
the more PPR entanglement is reduced (and remedy–placebo
entanglement increased) and the less a positive DBRCT
outcome is likely. It is true, however, that DBRCTs of
homeopathy do sometimes return (albeit small) positive
results. The standard response to this by those skeptical of
homeopathy’s efficacy is to suggest that the blinding in these
trials is not perfect (5). Another possibility is that these trials
represent some form of statistical fluctuation. In which case, it
is perhaps time that other statistical techniques (39,41) were
more commonly employed in clinical trials procedures (40). In
addition, alternative explanations have been advanced (27) in
terms of some surviving residual entanglement. For example,
the homeopathic remedy may be thought to entail the
entangled intention of those involved in its preparation
(43,44) without overarching patient–practitioner–remedy
entanglement to ‘lock’ the remedy into ‘therapeutic coher-
ence’, this residual entanglement might be enough to deliver
the relatively small clinical effect sizes sometimes observed in
DBRCTs of homeopathy. In another explanation, residual
entanglement may be thought of as surviving at the molecular
level from the production of the potentized remedy, via the
memory of water effect (45). The non-local coherence of
trillions of water molecules implied in the memory of water
hypothesis amounts to entanglement at the molecular level.
Thus, the intriguing possibility arises of describing the
homeopathic process in terms of various ‘layers’ of entangle-
ment, from the molecular up to the interactions of human
beings (46). Thus, it is too early to give a definitive answer as
to why some positive results are returned but a possible
experimental test of non-local communication in clinical trials
has been proposed (47). Now let us examine the effect on
homeopathic provings of applying the DBRCT methodology
of double-blinding and placebo control.
DBRCTs of HPTs (aka Provings)
The practice of homeopathy is founded on two pillars (48):
repertories of prescribing symptoms and its extensive material
medicae. In order for remedies to be included in a materia
medica their clinical properties need to be discovered and this
is done in ‘provings’, essentially HPTs. Here, an unknown
remedy is given to healthy volunteers and the symptoms
generated are recorded, collated and themes elucidated (49).
Homeopaths then use this gathered information in a compara-
tive manner (via repertorization after case-taking) to arrive at
a suitable prescription for a patient during treatment.
From the point of view of remedies, it is interesting to
assess treatment and proving scenarios in terms of information.
Thus, homeopathic treatment involves use of remedy infor-
mation by the practitioner after case taking. As previously
stated, DBRCT methodology effectively breaks entanglement
between patient, practitioner and remedy, in trials of
individualized homeopathic prescribing. This could be brought
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remedy that the homeopath and test subjects have to go
through, leading to a loss of information. A proving, on the
other hand, is a remedy information gathering exercise;
the accumulated knowledge eventually becoming part of the
materia medica.
Provings are not usually conducted in a double-blind
placebo-controlled manner. After proving symptoms have
been gathered, collation of the data allows a remedy picture
to emerge. However, two DBRCTs of HPTs have recently
been performed, and these showed that although there
were clear differences in proving symptoms between remedy
and placebo groups, there was also overlap or ‘leakage’ of
symptoms between them (50,51). These authors concluded
that remedy and placebo groups must have become entangled.
Interestingly, there has been some confirmation of this result
recently by another research group (52). What this could mean
is that in these proving DBRCTs, it is the loss of information
(about what is remedy and what is placebo) that leads to
entanglement formation.
This apparent contradiction between the DBRCT
(entanglement-breaking) treatment and (entanglement-
creating) proving situations is easily resolved when it is
realized that entanglement between remedy and placebo is
happening in both cases (however, in DBRCTs of homeo-
pathic treatment, this leads to the breaking of entanglement
between patient, practitioner and remedy). It suggests that it is
not so much the effect of blinding on the making or breaking of
entanglement that is important, rather the loss of information
that blinding produces which is common to both. Making or
breaking of entanglement can be seen therefore as epi-
phenomena of information loss brought on by blinding. This
could be the key which permits the superposition of states that
is the necessary condition for entanglement to occur. I shall
return to this point later. Let us now consider the similarity
between double-blind placebo-controlled provings and the
famous double-slit experiment of quantum physics.
The Double-Slit and Delayed Choice
Experiments
The double-slit experiment is one of those scientific classics
(53,54) as it has twice represented a turning point in our
understanding of the fundamental particles of nature. The
original experiment demonstrating the wave nature of light
was performed by the 19th century scientist Thomas Young,
and is shown in Fig. 1.
Thus, light is shone through a small hole in a screen, then
onto another screen, this time with two closely-spaced holes.
Light is diffracted through the two holes, spreads out and
falls onto a third screen to form an interference pattern of light
and shade (55).
The interference pattern can be best understood in terms
of two overlapping sets of waves, as might be produced
when two stones are dropped simultaneously into water.
Where the two patterns meet and merge, wave peaks can
interfere constructively (i.e. in-phase, they add together to
produce an enhanced peak) or destructively (i.e. exactly 180
o
out of phase, they cancel each other out). In the double-slit
experiment, in-phase constructively interfering light waves
produce a bright band, while out-of-phase destructively
interfering light waves produce a dark band (see Fig. 1).
However, other experiments, e.g. the photoelectric effect (54),
demonstrate that light also behaves as a stream of particles,
with each photon arriving in particulate fashion as a quantum,
apparently independently of others. Thus, bizarrely, light
seems to behave as waves or particles depending on the type
of experiment that is performed.
Even more bizarrely, similar double-slit experiments can be
performed on beams of particles, e.g. electrons, and even
atoms and molecules (56).As particles, one would expect them
to go through the slits and simply produce two patches of light
with no interference pattern. However, a beam of electrons
fired at a closely-spaced ‘double-slit’ (e.g. the serried ranks of
atoms in a crystal: this acts as a three-dimensional diffraction
grating—a series of slits—and is described by the same
physics and physical principles as a double-slit) will produce
an interference pattern of light and darkness on a scintillation
screen placed down-range from the slits. This demonstrates
that as far as traveling through the double-slit experiment is
concerned, ‘particle’ electrons are behaving as ‘waves’. But
the fact that each electron produces a spot on a screen (even
though the overall picture is one of an interference pattern)
means that each electron is arriving as a particle. Under these
circumstances, it might be thought possible to explain the
interference pattern as a statistical effect of there being large
numbers of particle-like electrons. This idea is dashed,
however, when examining the results of firing electrons singly
through the double-slit experiment, and the interference
pattern still emerges.
Each electron individually goes through the experiment and
strikes the screen to leave a spot. As spots build up, an
interference pattern emerges. This means that although in
lighting up the scintillation screen, each electron is behaving
as a particle. It also means that by forming an interference
pattern, each electron is behaving as a wave, and going
through both slits at the same time. In effect, each electron is
Figure 1. The double-slit experiment.
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the slits to try to detect which one each electron might be
going through [known as the delayed choice experiment (54)],
causes the interference pattern on the screen to disappear. In its
place are two clear spots, meaning that the electrons are now
behaving as particles, when going through one or other of
the slits, not both at the same time. Turning off the detector,
re-establishes the interference pattern on the screen.
The same thing is noticed if electrons are replaced by
photons of light or atoms or molecules. Thus, it is as if these
quantum entities seem to ‘know’ in advance when and where
they are being observed, the whole arrangement of the
experiment, including its past and its future, and change
their behavior accordingly. There is absolutely no way this
extremely bizarre experimentally verified behavior can be
explained according to the concepts of classical physics, and
is why Nobel Laureate Professor Richard Feynman described
the double-slit experiment as exemplifying ‘the central
mystery’ of quantum theory (53,54).
The double-slit and delayed choice experiments demonstrate
the true meaning of particle-wave duality, which is that the
whole experiment is an entangled entity: an entanglement
which, according to the quantum theory of measurement, must
include the states of the ‘classical’ (i.e. non-quantum)
apparatus set up to observe the system (and the human beings
making the observations: this is important to the analogy that
will be developed later on because in this respect, the patient
and practitioner may also be considered ‘classical pieces of
apparatus’ which nevertheless play host to the quantum states
being considered). The behavior of any quantum entityin these
experiments is affected by how we choose to observe it, but
clearly the effect of this choice of observation is felt before it
is made. Thus, from our everyday perspective, entangled
quantum correlations appear not only to be able to operate
instantaneously over space, but also over time itself (57).
The Double-Slit Experiment and Double-Blind
Placebo-Controlled Provings
It is instructive to consider the double-slit experiment as an
analogy to double-blind placebo-controlled provings. Thus,
the blinding of remedy and placebo may be thought of as akin
to the ‘double-slit’. In just the same way as in the double-slit
experiment it is unknown which hole an electron goes through
(unless it is observed, the wave function governing its
dynamics goes through both slits), so all involved in the
proving experiment are ignorant of their prescription.
The entangled nature of the electron ‘waves’ going through
the two slits is revealed by the interference pattern produced
when they arrive at the scintillation screen. (In fact entangle-
ment is usually used in a different sense, to express correla-
tions between different entities. In the case of an individual
electron going through both slits, entanglement is being used
to express the superposition of the two components of the
wave function representing the SAME entity.) Similarly,
entanglement of remedy and placebo is revealed after
observation of proving symptoms from human provers of the
remedy/placebo, and the identity of remedy and placebo has
been disclosed. Thus entanglement between the two groups of
human provers (i.e. those on verum and those on placebo) may
be thought of as an observed ‘interference’ pattern, produced
by the double-blinding.
One way of formulating this situation [there are others, see
(23,44,45,58)] is to use the algebraic formalism of quantum
theory. One has to bear in mind that human beings involved in
clinical trials of homeopathy (and any other CAM therapy), or
as provers in HPTs, are infinitely more complicated entities
than sub-atomic particles! With that codicil very much in
mind, in terms of wave functions, operators and expectation
values used previously to describe PPR entanglement in the
therapeutic process (22), an expression can be written relating
a remedy/placebo proving symptom entangled state and a
homeopathic observation operator, to a proving symptom
expectation value:
hCentjPojCenti¼h DSxið 7Þ
where Cent represents the remedy/placebo groups’ proving
symptom entangled state wave function (for all the provers);
Pois an operator representing the homeopathic coordinator(s)/
observer(s); and hDSxi represents the change in proving
symptom expectation value (without at this stage defining any
basis set for this expectation value). We may further define
the remedy/placebo entangled state in terms of three-way
PPR entanglement (28,59) between all provers on the remedy
PRx, all provers on the placebo PPl, and the homeopathic
observers PO:
jCenti¼
1
ﬃﬃﬃ
2
p jPRx"PPl"PO"þj PRX#PPl#PO#i ðÞ ð 8Þ
where PRx" and PRx# represent all provers on the remedy who
may or may not show symptoms; PPl" and PPl# represent all
provers on the placebo who may or not show symptoms; and
PO" and PO# represent all proving observers who may or may
not observe symptoms. As has been mentioned in earlier
papers on PPR entanglement (22,27,29), equations of type (8)
represent just two of a total of eight maximally entangled
states for three entangled entities. In terms of the double-slit
simile, the eight entangled states [two of which are shown in
Equation (8)] may be thought of as a superposition which
appears as an ‘interference pattern’ of entangled state proving
symptoms, which means RX and RPl cannot be distinguished.
Breaking Entanglement: The Price of
Information
It is interesting to consider how disentanglement of remedy
and placebo could be represented in terms of the double-slit
metaphor. Thus, in the double-slit experiment, observation
(i.e. gaining information) of electrons using a detector placed
after the slits, ‘collapses their wave function’ (60) throughout
12 Trials of homeopathy and homeopathic provingsthe whole experiment, so that they leave their source and arrive
at the screen as particles. This results in the interference
pattern disappearing to be replaced by two clear spots.
The equivalent situation in the double-blind placebo-
controlled proving is if provers and/or proving controllers/
observers know who has received the remedy and who has
received placebo. Thus, remedy and placebo are no longer
entangled (and the experiment can no longer be considered
double-blinded).
In terms of the previous section’s algebraic formulation, this
would mean collapse of the entangled state wave function,
so that Cent ¼ 0. This leaves the coordinators/observers in two
quite separate two-way entangled relationships: with remedy
provers and placebo provers. Thus:
  for the remedy:
hCRxjPOjCRxi¼h DSRxið 9Þ
  and:
jYRxi¼
1
ﬃﬃﬃ
2
p jPRx"PO"i ± jPRx#PO#i ðÞ ð 10Þ
  for the placebo:
hCPljPOjCPli¼h DSPlið 11Þ
  and:
jCPli¼
1
ﬃﬃﬃ
2
p jPPl"PO"i ± jPPl#PO#i ðÞ ð 12Þ
In two-way entanglement, it turns out that there are four
maximally entangled states (compared to eight for three
entangled objects) so that Equations (10) and (12) each
represent just two of these states (60). Also, as remedy and
placebo are now disentangled, provers on placebo should not
evince the symptoms shown by those on the remedy.
Consequently in Equation (11), either hDSPli¼0 or at least
hDSPli and hDSRxi cannot now be equated with each other.
In other words, the act of removing blinding (i.e. providing
information) should collapse the remedy/placebo entangled
state wave function, leaving two completely distinguishable
sets of results: one set for provers on the remedy, and one
set for those on placebo. In terms of the double-slit metaphor,
this would be analogous to the effect of observing the
electrons before they strike the screen (i.e. loss of the
interference pattern, which is replaced by two clearly defined
spots).
The preceding discussion suggests a possible experimental
test of this hypothesis. Thus, previous double-blind placebo-
controlled provings should be repeated on a much larger
sample of provers, but dividing the experiment into two halves
so that blinded and unblinded protocols may be included. One
half of the experiment would be double-blinded and placebo-
controlled as before, while the other half could be selectively
unblinded (e.g. either provers or coordinators) and used to
observe how remedy and placebo might disentangle. From this
perspective, the work of Schmidt et al. (47) in parapsychology
might also provide some useful pointers toward experimental
methodology.
Quantum States as Representations of
Knowledge
Quantum information processing is one of the most interesting
modern applications of quantum entanglement (4). Quantum
computing, cryptography and teleportation are now all
practically realizable technologies, at least in the laboratory
(60). They are predicated on the realization that information is
not independent of the quantum physical laws used to store and
process it. Though quantum mechanics governs the way
modern computers operate, the information they encode is still
treated classically. The latest insights into the very foundations
of quantum theory itself reveal that information is also subject
to the same quantum laws (61).
Thus, in quantum teleportation experiments, information can
completely and directly be transferred from one system to
another, without that information traveling down any physi-
cally identifiable signaling pathway. The ‘mechanism’ which
permits this direct transfer of information is quantum
entanglement, and is completely different to any communica-
tion system developed so far. The entangled systems are more
strongly coupled than classical systems, and together have
well-defined informational characteristics. On their own,
however, the individual systems may be completely random
without any information content. Successful quantum tele-
portation means that the new teleported system becomes
completely identical with the original, which by necessity has
to disappear.
In ‘classical’ information theory, the elementary quantity of
information is the bit which can have one of two values, e.g.
0 or 1. Physical realization of a bit requires any system which
can exist in two well-defined separate states. Where quantum
information technology differs from previous ‘classical’
information technologies, is that a quantum system can be
in a superposition of both the 0 and 1 states (called a qubit).
There is no parallel in classical information theory. Far from
superposition leading to a loss of information, it offers a
completely different way of encoding information onto two or
more qubits which actually uses the entangled superposition of
states. The information is encoded in such a way that neither of
the two qubits carries any well-defined information on its own:
all of the information is encoded in the joint properties of
their entangled state. Any attempt to ‘get at’ the presumed
information content of the individual qubits is doomed because
it means breaking the entanglement between them, leading to
the loss of information.
Quantum teleportation raises profound issues about the
nature of reality, especially at the quantum level. Thus,
information or knowledge of a system can have a more
fundamental meaning than the system’s objective reality or,
to put it even more starkly, we can only concern ourselves
eCAM 2007;(4)1 13with what can be known about the reality of a system;
not its presumed objective (ontological) ‘reality-in-itself’.
Measurement (observation) is what changes a quantum state
but it is in investing this state with too much ‘reality’ (as an
object ‘out there’, independent of our observation of it) that
leads to the well-known paradoxes of quantum theory, such as
Schro ¨dinger’s Cat (53,54). These conundra disappear if the
quantum state of a system is taken as a representation of
knowledge (what we can know) about it, not its presumed
objective ‘reality in itself’.
Although quantum teleportation works via entangled states
over a distance, it is also necessary to access a completely
separate and classical code in order to make any sense of the
encoding of information in the entangled states. This is an
additional requirement for the usage of information transfer
via entangled states, and explains the difference between
quantum information and classical information. However, this
raises the problem that entangled states in themselves cannot
be treated as if they could be the source of causal signals in the
classical sense: if treated as such, the entangled state is broken
and the information lost. [The explanation of this state of
affairs is a sophisticated argument which rests on the assump-
tion that the standard linear formalism of quantum mechanics
forbids the use of entanglement for superluminal (i.e. faster
than light or backwards in time) communication] (57).
Now, by analogy with quantum teleportation and quantum
encryption, clinical trials are by their very nature classical
‘detectors’ of causality. Consequently, they tend to regard
treatment groups as similar to causal signals, which can be
distilled out of sequences of clinical trials. This, it has been
argued, is one of the reasons why clinical trials cannot be used
for a detection of effects that are based on non-local
mechanisms: they lead to loss of information of entangled
states when ‘intercepted’ as causal signals (62,63).
The thrust of this and earlier papers in this series is that it
should be possible to use notions of quantum entanglement
(and by implication, information processing) to illustrate
certain features of the therapeutic process in homeopathy and
other CAMs. Consequently, the effects of investigating
homeopathy and other CAMs using blinded trial procedures
should also be amenable to such illustration. Thus, in double-
blinded provings (50,51), each of the components in the PPR
entangled state may be thought of as two-state ‘macro-qubits’
(e.g. Pr can be helpful or unhelpful; Px can be well or unwell;
and Rx can be curative or non-curative) and, therefore, by
implication, the homeopathic process might be considered to
involve macro-quantum ‘teleportation’. In this respect, the
idea of ‘macro-quantum teleportation’ would have certain
similarities to Walach’s notion of generalized entanglement,
based on semiotics (58,63,64). However, it is only the
entangled state which contains information about the whole
system. Thus, anything which breaks the entangled state will
necessarily lead to loss of information about the integration of
function of the systems as a whole system. Clearly, this could
happen in DBRCTs of homeopathic efficacy, where either the
remedy or patient and practitioner are removed from their
entangled therapeutic context (18,27). In the double-blind
proving situations, although information appears to be lost
about the individual remedy and placebo, the resulting
entanglement provides information about the whole experi-
mental situation.
Conclusion
Though still a controversial assertion, macroentanglement
could be a necessary concomitant of the homeopathic (indeed
many CAMs’) therapeutic process. Thus, the breaking of
macroentanglement (in this case, between patient, practitioner
and remedy) could explain the failure of DBRCTs to provide
unequivocal evidence for or against the efficacy of homeo-
pathy (18). Conversely, entanglement formation could explain
the inability of DBRCTs of HPTs to distinguish between
proving and placebo groups.
This apparent contradiction between DBRCTs of homeo-
pathic efficacy and homeopathic provings was explained in
terms of information loss brought about by quantum super-
position, i.e. entanglement formation, between the quantum
wave functions of remedy and placebo by the double-blinding
protocol. In the proving situation, similarities with the famous
double-slit experiment of quantum physics, and quantum
information processing are proposed.
Thus, in the double-slit experiment, the wave nature of
quantum particles is demonstrated by their formation of an
interference pattern on a screen. However, attempts to make
observations of this situation at one or other slit prior to the
waves arriving at the screen destroys the superposition, leading
to their behaving as particles. This demonstrates that super-
position is the key to their entanglement. In quantum
information processing, any attempt to isolate entangled
‘qubits’ leads to collapse of the entangled state and the loss
of information.
Therefore, an algebraic argument has been proposed that
if remedy and placebo really are entangled by application of
the DBRCT methodology to homeopathic provings, then any
attempt to have prior knowledge of them both should break
the entangled proving state. This should then deliver results
showing clear differences between remedy and placebo in
terms of proving symptoms. Thus, the use of DBRCTs for
testing homeopathy would appear to be a flawed strategy as
they seem to destroy the very effects they were purportedly
designed to investigate. Clearly, such a rationale could be
applied to many CAMs and perhaps even to DBRCTs of
conventional medicine. For as Nelson intimated, when one
looks at the world with a blind eye, one tends not to see
anything.
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